查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1490319

細胞治療包裝市場：產業趨勢與全球預測（-2035）-依標靶治療類型、包裝工程設計、業務規模和主要地理區域

Cell Therapy Packaging Market, Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Therapy Packed, Package Engineering Design, Scale of Operation and Key Geographical Regions
出版日期: | 出版商: Roots Analysis | 英文 204 Pages | 商品交期: 最快1-2個工作天內

價格

細胞治療包裝市場規模預計到 2024 年將達到 3.61 億美元，並在 2024-2035 年預測期內複合年增長率為 11.8%。

細胞療法涉及使用患者自己的細胞（自體細胞）或來自健康捐贈者的細胞（同種異體細胞），這些細胞經過基因重新編程以對抗各種疾病。患者被注射可能具有治療效果的活細胞。值得注意的是，細胞和基因療法正在用於治療各種對治療構成重大課題的罕見遺傳疾病，包括癌症、關節炎、失智症和白血病。目前，超過30種細胞和基因治療藥物已獲得FDA批准，許多治療候選藥物正在臨床開發中取得進展。近年來，細胞療法引起了醫療保健界的廣泛關注，因為其在治療罕見疾病方面的巨大潛力得到了充分的臨床證據的支持，證明了其治療功效和潛力。

細胞治療的成功取決於能否安全、及時地向適當的患者輸送大量可行的治療細胞。此外，在整個供應鏈中維持特定的溫度條件（因療法而異）對於維持細胞治療藥物的穩定性和完整性至關重要。這些處理方法在製造的每個階段都受到嚴格的監管，以確保符合包裝產品的品質標準。由於細胞治療包裝空間的複雜性，許多藥物開發公司將包裝需求外包給合約研究組織 (CRO)。在細胞療法需求不斷增長的推動下，細胞療法包裝服務市場預計在預測期內將大幅成長。

本報告調查了全球細胞治療包裝市場，並提供了市場概況，以及依靶向治療類型、包裝工程設計、業務規模、主要地區和進入市場的公司等劃分的趨勢。

目錄

第一章前言

第 2 章執行摘要

第 3 章簡介

第 4 章細胞治療包裝服務提供者：市場狀況

  • 章節概述
  • 細胞治療包裝服務提供者：整體市場格局

第五章細胞治療包裝產品供應商：市場情勢

  • 章節概述
  • 細胞治療包裝產品：市場狀況
  • 細胞療法包裝：產品供應商格局

第 6 章細胞治療包裝服務與產品提供者：公司簡介

  • 章節概述
  • 細胞治療包裝服務提供者
  • 細胞治療包裝產品提供者

第七章企業競爭分析

  • 章節概述
  • 主要參數
  • 調查方法
  • 細胞治療包裝服務提供者：公司競爭分析

第 8 章夥伴關係與協作

  • 章節概述
  • 合作夥伴模式
  • 細胞治療包裝：合作夥伴與協作列表

第九章合作夥伴候選人分析

第 10 章細胞療法開發商和製造商：案例研究

  • 章節概述
  • 細胞療法製造商：市場狀況

第 11 章全球細胞治療套餐市場

  • 章節概述
  • 假設與研究方法
  • 全球細胞治療包裝服務市場預測（2024-2035）
  • 情境分析
  • 主要市場細分

第十二章細胞治療包裝市場（依目標治療類型）

第十三章細胞治療包裝市場（依業務規模）

第14章細胞治療包裝市場（依包裝工程設計）

第十五章細胞治療包裝市場（依主要地區）

第16章結論

第 17 章附錄 1：表格資料

第十八章附錄2：公司與組織名單

Product Code: RA100279

Cell Therapy Packaging Market, Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Therapy Packed (T-cell therapies, dendritic cell vaccines, stem cell therapies, NK-Cell therapies and other ATMPs), Package Engineering Design (primary and secondary packaging), Scale of Operation (clinical and commercial) and Key Geographical Regions (North America, Europe, Asia Pacific and Rest of the World)

The Cell Therapy Packaging Market is valued at USD 361 million in 2024 growing at a CAGR of 11.8% during the forecast period 2024-2035.

Cell therapy involves utilizing a patient's own cells (autologous) or cells from a healthy donor (allogeneic), which are genetically re-programmed to combat various diseases. Patients receive injections of viable cells that are expected to provide therapeutic benefits. Notably, cell and gene therapies have been employed to address a spectrum of rare and genetic medical conditions, including cancer, arthritis, dementia, leukemia, and others that pose significant treatment challenges. Presently, over 30 cell and gene therapies have gained FDA approvals, with numerous therapeutic candidates advancing through clinical development stages. In recent years, cell therapy has garnered substantial attention from healthcare industry stakeholders due to its immense potential in treating rare disorders, supported by a robust body of clinical evidence demonstrating its therapeutic benefits and potential.

The success of cell therapies hinges on the safe and timely delivery of viable therapeutic cell doses to the appropriate patients. Additionally, maintaining specific temperature conditions (depending on the therapy) throughout the supply chain is crucial to preserving the stability and integrity of cell therapy drug products. These therapies undergo stringent regulatory scrutiny at each manufacturing step to ensure packaging product quality standards are met. Given the complexities involved in the cell therapy packaging realm, numerous drug developers are opting to outsource their packaging needs to Contract Research Organizations (CROs). Driven by the increasing demand for cell-based therapeutics, the market for cell therapy packaging services is poised to witness significant growth in the forecast period.

Key Market Segments

Type of Therapy Packed

  • T-cell Therapies
  • Dendritic Cell Vaccines
  • Stem Cell Therapies
  • NK-cell Therapies
  • Other Advanced Therapy Medicinal Products

Scale of Operations

  • Clinical Scale
  • Commercial Scale

Package Engineering Design

  • Primary Packaging
  • Secondary Packaging

Key Geographical Regions

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Research Coverage:

  • Comprehensive overview of current market landscape of cell therapy packaging services providers, including a detailed analysis based on their year of establishment, company size, location of headquarters, type of services offered (packaging, distribution, storage, labeling, manufacturing, management solutions, drug return & destruction, serialization, analytical and other services), type of packaging (active and passive packaging), type of passive system offered (dry shippers and VIP insulations), packaging engineering design (primary and secondary packaging), phase change material used (dry ice and liquid nitrogen).
  • A detailed analysis of the current market landscape of cell therapy packaging products, providing information on type of packaging container (bag, vial, shipping container and others), type of container fabrication material (plastic and others), raw materials for container fabrication (ethylene vinyl acetate (EVA), insulated panel, polypropylene, fluorinated ethylene propylene, USP class VI materials, polyethylene and others), type of cells packed (blood cells, hematopoietic cells, lymphocytes, stem cells, mesenchymal cells, cord blood cells, induced pluripotent cells and chondrocytes), storage conditions (ambient, refrigerated, freezing and cryogenic temperatures), and usability of container (single-use and multiple-use products). Further, the product providers have also been analyzed on the basis of parameters, such as their year of establishment, company size, location of headquarters and most active players (in terms of number of products).
  • Detailed company profiles of key players (shortlisted based on a proprietary criterion) in offering cell therapy packaging products and services. Each profile features a brief overview of the company, details related to its service portfolio / product portfolio, recent developments and an informed future outlook.
  • An in-depth competitiveness assessment of cell therapy packaging service providers based across different geographies, by taking into consideration the service strength of a company (based on its experience), packaging portfolio (package engineering design, type of packaging, type of packaging material and temperature ranges supported), service portfolio (type of additional services offered).
  • Comprehensive assessment of the different partnerships established between cell therapy packaging providers and cell therapy developers, during the period 2016-2021. It includes a brief description of various types of partnership models (namely service alliance, technology / platform integration agreement, merger and acquisition) adopted by stakeholders in this domain. It is worth mentioning that the data captured during our research was analyzed based on several parameters, such as year of partnership, type of partnership, purpose of partnership, type of service offered, and geographical location of players involved in the partnership.
  • A list of over 250 cell therapy developers anticipated to partner with cell therapy packaging providers, which have been shortlisted on the basis of developer strength (based on company size), type of therapy and pipeline maturity (based on stage of development of drug candidate).
  • A case study highlighting the players, claiming to have the required expertise and capabilities for development and manufacturing of cell therapies, along with the information on their year of establishment, company size, location of headquarters and location of manufacturing facility. In addition, the chapter presents analysis on type of cells manufactured, source of cells, scale of operation and manufacturing capabilities / services of the aforementioned companies.
  • Comprehensive cell therapy packaging market forecast to estimate the current market size and future opportunity over the next 11 years. Based on multiple parameters, likely adoption of cell therapy packaging products and services and through secondary sources, we have provided an informed estimate on the market size during the forecast period 2024-2035.
  • Comprehensive projections of the current and future opportunity within the cell therapy packaging market across different type of therapies packed, such as T-cell therapies, dendritic cell vaccines, stem cell therapies, NK-cell therapies and other advanced therapy medicinal products.
  • Detailed predictions of the current and future opportunity within the cell therapy packaging market based on different scales of operations, such as clinical and commercial.
  • Comprehensive predictions of the current and future cell therapy packaging market based on different package engineering designs, such as primary packaging and secondary packaging.
  • Detailed predictions of the current and future opportunity within the cell therapy packaging market based on key geographical regions, such as North America, Europe, Asia-Pacific and Rest of the World.

Key Benefits of Buying this Report

  • The report offers market leaders and newcomers valuable insights into revenue estimations for both the overall market and its sub-segments.
  • Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
  • The report provides stakeholders with a pulse on the Cell Therapy Packaging Market, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.

Leading Market Companies

  • Almac
  • Catalent Biologics
  • Cryoport Systems
  • Saint-Gobain
  • Thermo Fisher Scientific
  • West Pharmaceuticals
  • Yourway

TABLE OF CONTENTS

Table Of Contents

1. PREFACE

  • 1.1. Scope of the Report
  • 1.2. Research Methodology
  • 1.3. Key Questions Answered
  • 1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

  • 3.1. Chapter Overview
  • 3.2. Pharmaceutical Filling and Packaging
  • 3.3. Importance of Pharmaceutical Packaging
  • 3.4. Types of Pharmaceutical Packaging
  • 3.5. Packaging of Cell Therapies
    • 3.5.1. Primary Packaging
    • 3.5.2. Secondary Packaging
  • 3.6. Cell Therapy Packaging: Key Considerations
  • 3.7. Challenges associated with Cell Therapy Packaging
  • 3.8. Concluding Remarks

4. CELL THERAPY PACKAGING SERVICE PROVIDERS: MARKET LANDSCAPE

  • 4.1. Chapter Overview
  • 4.2. Cell Therapy Packaging Service Providers: Overall Market Landscape
    • 4.2.1. Analysis by Year of Establishment
    • 4.2.2. Analysis by Company Size
    • 4.2.3. Analysis by Location of Headquarters
    • 4.2.4. Analysis by Services Offered
    • 4.2.5. Analysis by Type of Packaging
    • 4.2.6. Analysis by Type of Passive System Offered
    • 4.2.7. Analysis by Type of Package Engineering Design
    • 4.2.8. Analysis by Phase Change Material Used
    • 4.2.9. Analysis by Temperature Ranges Supported
    • 4.2.10. Analysis by Type of Cells Handled

5. CELL THERAPY PACKAGING PRODUCT PROVIDERS: MARKET LANDSCAPE

  • 5.1. Chapter Overview
  • 5.2. Cell Therapy Packaging Products: Market Landscape
    • 5.2.1. Analysis by Type of Packaging Container
    • 5.2.2. Analysis by Container Fabrication Material and Raw Materials for Container Fabrication
    • 5.2.3. Analysis by Type of Cells Packed
    • 5.2.4. Analysis by Storage Conditions
    • 5.2.5. Analysis by Usability of Container
  • 5.3. Cell Therapy Packaging: Product Providers Landscape
    • 5.3.1. Analysis by Year of Establishment
    • 5.3.2. Analysis by Company Size
    • 5.3.3. Analysis by Location of Headquarters
    • 5.3.4. Most Active Players: Distribution by Number of Products

6. CELL THERAPY PACKAGING SERVICE AND PRODUCT PROVIDERS: COMPANY PROFILES

  • 6.1. Chapter Overview
  • 6.2 Cell Therapy Packaging Service Providers
    • 6.2.1. Almac
      • 6.2.1.1. Company Overview
      • 6.2.1.2. Cell Therapy Service Portfolio
      • 6.2.1.3. Recent Developments and Future Outlook
    • 6.2.2. Catalent Biologics
      • 6.2.2.1. Company Overview
      • 6.2.2.2. Cell Therapy Service Portfolio
      • 6.2.2.3. Recent Developments and Future Outlook
    • 6.2.3. Cryoport Systems
      • 6.2.3.1. Company Overview
      • 6.2.3.2. Cell Therapy Service Portfolio
      • 6.2.3.3. Recent Developments and Future Outlook
    • 6.2.4. Yourway
      • 6.2.4.1. Company Overview
      • 6.2.4.2. Cell Therapy Service Portfolio
      • 6.2.4.3. Recent Developments and Future Outlook
  • 6.3. Cell Therapy Packaging Product Providers
    • 6.3.1. Saint-Gobain Life Sciences
      • 6.3.1.1. Company Overview
      • 6.3.1.2. Cell Therapy Packaging Product Portfolio
      • 6.3.1.3. Recent Developments and Future Outlook
    • 6.3.2. Thermo Fisher Scientific
      • 6.3.2.1. Company Overview
      • 6.3.2.2. Cell Therapy Packaging Product Portfolio
      • 6.3.2.3. Recent Developments and Future Outlook
    • 6.3.3. West Pharmaceutical Services
      • 6.3.3.1. Company Overview
      • 6.3.3.2. Cell Therapy Packaging Product Portfolio
      • 6.3.3.3. Recent Developments and Future Outlook

7. COMPANY COMPETITIVENESS ANALYSIS

  • 7.1. Chapter Overview
  • 7.2. Key Parameters
  • 7.3. Methodology
  • 7.4. Cell Therapy Packaging Service Providers: Company Competitiveness Analysis
    • 7.4.1. Companies based in North America
    • 7.4.2. Companies based in Europe and Asia-Pacific

8. PARTNERSHIPS AND COLLABORATIONS

  • 8.1. Chapter Overview
  • 8.2. Partnership Models
  • 8.3. Cell Therapy Packaging: List of Partnerships and Collaborations
    • 8.3.1. Analysis by Year of Partnership
    • 8.3.2. Analysis by Type of Partnership
    • 8.3.3. Analysis by Year and Type of Partnership
    • 8.3.4. Analysis by Purpose of Partnership
    • 8.3.5. Analysis by Type of Service(s) Covered
    • 8.3.6. Most Active Players: Analysis by Number of Partnerships
    • 8.3.7. Regional Analysis
    • 8.3.8. Intercontinental and Intracontinental Agreements

9. LIKELY PARTNER ANALYSIS

  • 9.1. Chapter Overview
  • 9.2. Scope and Methodology
  • 9.3. Potential Strategic Partners for Cell Therapy Packaging Providers in North America
    • 9.3.1. Most Likely Partners
    • 9.3.2. Likely Partners
    • 9.3.3. Less Likely Partners
  • 9.4. Potential Strategic Partners for Cell Therapy Packaging Providers in Europe
    • 9.4.1. Most Likely Partners
    • 9.4.2. Likely Partners
    • 9.4.3. Less Likely Partners
  • 9.5. Potential Strategic Partners for Cell Therapy Packaging Providers in Asia Pacific and Rest of the World
    • 9.5.1. Most Likely Partners
    • 9.5.2. Likely Partners
    • 9.5.3. Less Likely Partners

10. CELL THERAPY DEVELOPERS AND MANUFACTURERS: CASE STUDY

  • 10.1. Chapter Overview
  • 10.2. Cell Therapy Manufacturers: Overall Market Landscape
    • 10.2.1. Analysis by Year of Establishment
    • 10.2.2. Analysis by Company Size
    • 10.2.3. Analysis by Location of Headquarters
    • 10.2.4. Analysis by Location of Manufacturing Facility
    • 10.2.5. Analysis by Type of Cell(s) Manufactured
    • 10.2.6. Analysis by Source of Cells
    • 10.2.7. Analysis by Scale of Operation
    • 10.2.8. Analysis by Manufacturing Capabilities / Services
    • 10.2.9. Concluding Remarks

11. GLOBAL CELL THERAPY PACKAGING MARKET

  • 11.1. Chapter Overview
  • 11.2. Assumptions and Methodology
  • 11.3. Global Cell Therapy Packaging Services Market, Forecasted Estimates (2024-2035)
  • 11.4. Scenario Analysis
    • 11.4.1. Conservative Scenario
    • 11.4.2. Optimistic Scenario
  • 11.5. Key Market Segmentations

12. CELL THERAPY PACKAGING MARKET, BY TYPE OF THERAPY

  • 12.1. Chapter Overview
  • 12.2. Key Assumptions and Methodology
  • 12.3. Cell Therapy Packaging Market: Distribution by Type of Therapy
    • 12.3.1. T-cell Therapies Packaging: Forecasted Estimates (2024-2035)
    • 12.3.2. Dendritic Cell Vaccines Packaging: Forecasted Estimates (2024-2035)
    • 12.3.3. Stem Cell Therapies Packaging: Forecasted Estimates (2024-2035)
    • 12.3.4. NK-Cell Therapies Packaging: Forecasted Estimates (2024-2035)
    • 12.3.5. Other Advanced Therapy Medicinal Products Packaging: Forecasted Estimates (2024-2035)
  • 12.4. Data Triangulation and Validation

13. CELL THERAPY PACKAGING MARKET, BY SCALE OF OPERATION

  • 13.1. Chapter Overview
  • 13.2. Key Assumptions and Methodology
  • 13.3. Cell Therapy Packaging Market: Distribution by Scale of Operation
    • 13.3.1. Clinical Scale: Forecasted Estimates (2024-2035)
    • 13.3.2. Commercial Scale: Forecasted Estimates (2024-2035)
  • 13.4. Data Triangulation and Validation

14. CELL THERAPY PACKAGING MARKET, BY PACKAGE ENGINEERING DESIGN

  • 14.1. Chapter Overview
  • 14.2. Key Assumptions and Methodology
  • 14.3. Cell Therapy Packaging Market: Distribution by Package Engineering Design
    • 14.3.1. Primary Packaging: Forecasted Estimates (2024-2035)
    • 14.3.2. Secondary Packaging: Forecasted Estimates (2024-2035)
  • 14.4. Data Triangulation and Validation

15. CELL THERAPY PACKAGING MARKET, BY KEY GEOGRAPHICAL REGIONS

  • 15.1. Chapter Overview
  • 15.2. Key Assumptions and Methodology
  • 15.3. Cell Therapy Packaging Market: Distribution by Key Geographical Regions
    • 15.3.1. North America: Forecasted Estimates (2024-2035)
    • 15.3.2. Europe: Forecasted Estimates (2024-2035)
    • 15.3.3. Asia-Pacific: Forecasted Estimates (2024-2035)
    • 15.3.4. Rest of the World: Forecasted Estimates (2024-2035)
  • 15.4. Data Triangulation and Validation

16. CONCLUDING REMARKS

  • 16.1. Chapter Overview

17. APPENDIX 1: TABULATED DATA

18. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List of Tables

  • Table 4.1 Cell Therapy Packaging Service Providers: List of Industry Players
  • Table 4.2 Cell Therapy Packaging Service Providers Market: Information on Services Offered
  • Table 4.3 Cell Therapy Packaging Service Providers Market: Information on Type of Packaging
  • Table 4.4 Cell Therapy Packaging Service Providers Market: Information on Type of Passive System Used
  • Table 4.5 Cell Therapy Packaging Service Providers Market: Information on Type of Packaging
  • Table 4.6 Cell Therapy Packaging Service Providers Market: Information on Phase Change Material
  • Table 4.7 Cell Therapy Packaging Service Providers Market: Information on Temperature Ranges
  • Table 4.8 Cell Therapy Packaging Service Providers Market: Information on Type of Cells Handled Supported
  • Table 5.1 Cell Therapy Packaging Product Providers: Information on Type of Packaging Container
  • Table 5.2 Cell Therapy Packaging Product Providers: Information on Type of Container Fabrication Material and Raw Material for Container Fabrication
  • Table 5.3 Cell Therapy Packaging Product Providers Market: Information on Type of Cells Packed
  • Table 5.4 Cell Therapy Packaging Product Providers: Information on Storage Conditions
  • Table 5.5 Cell Therapy Packaging Product Providers: Information on Packaging Volume, Customization and Usability of Container
  • Table 5.6 Cell Therapy Packaging Product Providers: List of Industry Players
  • Table 6.1 Cell Therapy Packaging Service and Product Providers: List of Companies Profiled
  • Table 6.2 Almac: Company Snapshot
  • Table 6.3 Almac: Recent Developments and Future Outlook
  • Table 6.4 Cryoport Systems: Company Snapshot
  • Table 6.5 Cryoport Systems: Recent Developments and Future Outlook
  • Table 6.6 Catalent Biologics: Company Snapshot
  • Table 6.7 Catalent Biologics: Recent Developments and Future Outlook
  • Table 6.8 Yourway: Company Snapshot
  • Table 6.9 Saint-Gobain Life Sciences: Company Snapshot
  • Table 6.10 Saint-Gobain Life Sciences: Product Portfolio
  • Table 6.11 Thermo Fisher Scientific: Company Snapshot
  • Table 6.12 Thermo Fisher Scientific: Product Portfolio
  • Table 6.13 Thermo Fisher Scientific: Recent Developments and Future Outlook
  • Table 6.14 West Pharmaceutical Services: Company Snapshot
  • Table 6.15 West Pharmaceutical Services: Product Portfolio
  • Table 6.16 West Pharmaceutical Services: Recent Developments and Future Outlook
  • Table 7.1 Cell Therapy Packaging: List of Partnerships and Collaborations, 2016-2021
  • Table 7.2 Partnerships and Collaborations: Information on Type of Service(s) Covered
  • Table 9.1 Most Likely Partners for Cell Therapy Packaging Product and Service Providers in North America
  • Table 9.2 Likely Partners for Cell Therapy Packaging Product and Service Providers in North America
  • Table 9.3 Less Likely Partners for Cell Therapy Packaging Product and Service Providers in North America
  • Table 9.4 Most Likely Partners for Cell Therapy Packaging Product and Service Providers in Europe
  • Table 9.5 Likely Partners for Cell Therapy Packaging Product and Service Providers in Europe
  • Table 9.6 Less Likely Partners for Cell Therapy Packaging Product and Service Providers in Europe
  • Table 9.7 Most Likely Partners for Cell Therapy Packaging Product and Service Providers in Asia Pacific and RoW
  • Table 9.8 Likely Partners for Cell Therapy Packaging Product and Service Providers in Asia Pacific and RoW
  • Table 9.9 Less Likely Partners for Cell Therapy Packaging Product and Service Providers in Asia Pacific and RoW
  • Table 10.1 Cell Therapy Manufacturers: List of Industry Players
  • Table 10.2 Cell Therapy Manufacturers: Information on Type of Cells Manufactured
  • Table 10.3 Cell Therapy Manufacturers: Information on Source of Cells
  • Table 10.4 Cell Therapy Manufacturers: Information on Scale of Operation
  • Table 10.5 Cell Therapy Manufacturers: Information on Type of Manufacturing Capabilities / Services
  • Table 17.1 Cell Therapy Packaging Service Providers: Distribution by Year of Establishment
  • Table 17.2 Cell Therapy Packaging Service Providers: Distribution by Company Size
  • Table 17.3 Cell Therapy Packaging Service Providers: Distribution by Location of Headquarters
  • Table 17.4 Cell Therapy Packaging Service Providers: Distribution by Package Engineering Design
  • Table 17.5 Cell Therapy Packaging Service Providers: Distribution by Type of Packaging
  • Table 17.6 Cell Therapy Packaging Service Providers: Distribution by Packaging Material
  • Table 17.7 Cell Therapy Packaging Service Providers: Distribution by Type of Packaging and Packaging Material
  • Table 17.8 Cell Therapy Packaging Service Providers: Distribution by Type of Passive System Used
  • Table 17.9 Cell Therapy Packaging Service Providers: Distribution by Temperature Ranges Supported
  • Table 17.10 Cell Therapy Packaging Service Providers: Distribution by Type of Packaging, Packaging Material and Temperature Ranges Supported
  • Table 17.11 Cell Therapy Packaging Service Providers: Distribution by Type of Cells Handled
  • Table 17.12 Cell Therapy Packaging Service Providers: Distribution by Type of Additional Services Offered
  • Table 17.13 Cell Therapy Packaging Products: Distribution by Type of Packaging Container
  • Table 17.14 Cell Therapy Packaging Products: Distribution by Container Fabrication Material
  • Table 17.15 Cell Therapy Packaging Products: Distribution by Type of Packaging Container and Container Fabrication Material
  • Table 17.16 Cell Therapy Packaging Products: Distribution by Storage Temperature Conditions
  • Table 17.17 Cell Therapy Packaging Products: Distribution by Type of Container and Storage Temperature Conditions
  • Table 17.18 Cell Therapy Packaging Products: Distribution by Type of Cells Packed
  • Table 17.19 Cell Therapy Packaging Products: Distribution by Usability of Container
  • Table 17.20 Cell Therapy Packaging Product Providers: Distribution by Year of Establishment
  • Table 17.21 Cell Therapy Packaging Product Providers: Distribution by Company Size
  • Table 17.22 Cell Therapy Packaging Product Providers: Distribution by Location of Headquarters
  • Table 17.23 Partnerships and Collaborations: Cumulative Year-wise Trend, 2016-2021 (till April)
  • Table 17.24 Partnerships and Collaborations: Distribution by Type of Partnership
  • Table 17.25 Partnerships and Collaborations: Distribution by Year and Type of Partnership, 2016-2021 (till April)
  • Table 17.26 Partnerships and Collaborations: Distribution by Purpose of Partnerships
  • Table 17.27 Partnerships and Collaborations: Distribution by Type of Service(s) Covered
  • Table 17.28 Most Active Players: Distribution by Number of Partnerships
  • Table 17.29 Partnerships and Collaborations: Distribution by Location of Parent Company
  • Table 17.30 Partnerships and Collaborations: Distribution by Location of Partner Company
  • Table 17.31 Partnerships and Collaborations: Distribution by Intercontinental and Intracontinental Partnerships
  • Table 17.32 Cell Therapy Manufacturers: Distribution by Year of Establishment
  • Table 17.33 Cell Therapy Manufacturers: Distribution by Company Size
  • Table 17.34 Cell Therapy Manufacturers: Distribution by Location of Headquarters
  • Table 17.35 Cell Therapy Manufacturers: Distribution by Location of Headquarters (Country Wise)
  • Table 17.36 Cell Therapy Manufacturers: Distribution by Location of Manufacturing Facility (Region-wise)
  • Table 17.37 Cell Therapy Manufacturers: Distribution by Location of Manufacturing Facility (Country-wise)
  • Table 17.38 Cell Therapy Manufacturers: Distribution by Type of Cells Manufactured
  • Table 17.39 Cell Therapy Manufacturers: Distribution by Type of Manufacturers
  • Table 17.40 Cell Therapy Manufacturers: Distribution by Source of Cells
  • Table 17.41 Cell Therapy Manufacturers: Distribution by Scale of Operation
  • Table 17.42 Cell Therapy Manufacturers: Distribution by Manufacturing Capabilities / Services
  • Table 17.43 Global Cell Therapy Packaging Market, Forecasted Estimates (2024-2035) (USD Million)
  • Table 17.44 Global Cell Therapy Packaging Market, Forecasted Estimates (2024-2035), Conservative Scenario (USD Million)
  • Table 17.45 Global Cell Therapy Packaging Market, Forecasted Estimates (2024-2035), Optimistic Scenario (USD Million)
  • Table 17.46 Global Cell Therapy Packaging Market: Distribution by Type of Therapy, 2024 and 2035 (USD Million)
  • Table 17.47 Cell Therapy Packaging Market for T-cell Therapies Packaging, Forecasted Estimates (2024-2035) (USD Million)
  • Table 17.48 Cell Therapy Packaging Market for Stem Cell Therapies Packaging, Forecasted Estimates (2024-2035) (USD Million)
  • Table 17.49 Cell Therapy Packaging Market for Dendritic Cell Vaccines Packaging, Forecasted Estimates (2024-2035) (USD Million)
  • Table 17.50 Cell Therapy Packaging Market for NK-Cell Therapies Packaging, Forecasted Estimates (2024-2035) (USD Million)
  • Table 17.51 Cell Therapy Packaging Market for Other Advanced Therapy Medicinal Products Packaging, Forecasted Estimates (2024-2035) (USD Million)
  • Table 17.52 Global Cell Therapy Packaging Market: Distribution by Scale of Operation, 2024 and 2035 (USD Million)
  • Table 17.53 Cell Therapy Packaging Market for Clinical Scale, Forecasted Estimates (2024-2035) (USD Million)
  • Table 17.54 Cell Therapy Packaging Market for Commercial Scale, Forecasted Estimates (2024-2035) (USD Million)
  • Table 17.55 Global Cell Therapy Packaging Market: Distribution by Package Engineering Design, 2024 and 2035 (USD Million)
  • Table 17.56 Cell Therapy Packaging Market for Primary Packaging, Forecasted Estimates (2024-2035) (USD Million)
  • Table 17.57 Cell Therapy Packaging Market for Secondary Packaging, Forecasted Estimates (2024-2035) (USD Million)
  • Table 17.58 Global Cell Therapy Packaging Market: Distribution by Key Geographical Regions, 2024 and 2035 (USD Million)
  • Table 17.59 Cell Therapy Packaging Market for North America, Forecasted Estimates (2024-2035) (USD Million)
  • Table 17.60 Cell Therapy Packaging Market for Europe, Forecasted Estimates (2024-2035) (USD Million)
  • Table 17.61 Cell Therapy Packaging Market for Asia-Pacific, Forecasted Estimates (2024-2035) (USD Million)
  • Table 17.62 Cell Therapy Packaging Market for Rest of the World, Forecasted Estimates (2024-2035) (USD Million)

List of Figures

  • Figure 2.1 Executive Summary: Service Providers Landscape
  • Figure 2.2 Executive Summary: Product Providers Landscape
  • Figure 2.3 Executive Summary: Partnerships and Collaborations
  • Figure 2.4 Executive Summary: Market Forecast and Opportunity Analysis
  • Figure 3.1 Traditional Aseptic Pharmaceutical Filling
  • Figure 3.2 Advantages of Pharmaceutical Packaging
  • Figure 3.3 Types of Pharmaceutical Packaging
  • Figure 3.4 Packaging Containers for Cell Therapies
  • Figure 3.5 Challenging aspects of Cell Therapy Packaging
  • Figure 4.1 Cell Therapy Packaging Service Providers: Distribution by Year of Establishment
  • Figure 4.2 Cell Therapy Packaging Service Providers: Distribution by Company Size
  • Figure 4.3 Cell Therapy Packaging Service Providers: Distribution by Location of Headquarters
  • Figure 4.4 Cell Therapy Packaging Service Providers: Distribution by Company Size and Location of Headquarters
  • Figure 4.5 Cell Therapy Packaging Service Providers: Distribution by Services Offered
  • Figure 4.6 Cell Therapy Packaging Service Providers: Distribution by Type of Packaging
  • Figure 4.7 Cell Therapy Packaging Service Providers: Distribution by Passive System Used
  • Figure 4.8 Cell Therapy Packaging Service Providers: Distribution by Package Engineering Design
  • Figure 4.9 Cell Therapy Packaging Service Providers: Distribution by Type of Phase Change Material
  • Figure 4.10 Cell Therapy Packaging Service Providers: Distribution by Type of Packaging and Phase Change Material
  • Figure 4.11 Cell Therapy Packaging Service Providers: Distribution by Temperature Ranges Supported
  • Figure 4.12 Cell Therapy Packaging Service Providers: Distribution by Type of Packaging, Packaging Material and Temperature Ranges Supported
  • Figure 4.13 Cell Therapy Packaging Service Providers: Distribution by Type of Cells Handled
  • Figure 5.1 Cell Therapy Packaging Products: Distribution by Type of Packaging Container
  • Figure 5.2 Cell Therapy Packaging Products: Distribution by Container Fabrication Material and Raw Materials for Container Fabrication
  • Figure 5.3 Cell Therapy Packaging Products: Distribution by Type of Packaging and Type of Container Fabrication Material
  • Figure 5.4 Cell Therapy Packaging Products: Distribution by Type of Cells Packed
  • Figure 5.5 Cell Therapy Packaging Products: Distribution by Storage Temperature
  • Figure 5.6 Cell Therapy Packaging Products: Distribution by Usability of Container
  • Figure 5.7 Cell Therapy Packaging Product Providers: Distribution by Year of Establishment
  • Figure 5.8 Cell Therapy Packaging Product Providers: Distribution by Company Size
  • Figure 5.9 Cell Therapy Packaging Product Providers: Distribution by Location of Headquarters
  • Figure 5.10 Cell Therapy Packaging Product Providers: Distribution by Company Size and Location of Headquarters
  • Figure 5.11 Key Cell Therapy Packaging Product Providers: Distribution by Number of Products
  • Figure 6.1 Almac: Cell Therapy Service Portfolio
  • Figure 6.2 Catalent Biologics: Cell Therapy Service Portfolio
  • Figure 6.3 Cryoport Systems: Cell Therapy Service Portfolio
  • Figure 6.4 Yourway: Cell Therapy Service Portfolio
  • Figure 7.1 Company Competitiveness Analysis: Cell Therapy Packaging Service Providers based in North America
  • Figure 7.2 Company Competitiveness Analysis: Cell Therapy Packaging Service Providers based in Europe and Asia-Pacific
  • Figure 8.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2016-2021
  • Figure 8.2 Partnerships and Collaborations: Distribution by Type of Partnership
  • Figure 8.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership, 2016-2021 (till April)
  • Figure 8.4 Partnerships and Collaborations: Distribution by Purpose of Partnership
  • Figure 8.5 Partnerships and Collaborations: Distribution by Type of Service(s) Covered
  • Figure 8.6 Most Active Players: Distribution by Number of Partnerships
  • Figure 8.7 Partnerships and Collaborations: Distribution by Location of Parent Company
  • Figure 8.8 Partnerships and Collaborations: Distribution by Location of Partner Company
  • Figure 8.9 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
  • Figure 10.1 Cell Therapy Manufacturers: Distribution by Year of Establishment
  • Figure 10.2 Cell Therapy Manufacturers: Distribution by Company Size
  • Figure 10.3 Cell Therapy Manufacturers: Distribution by Location of Headquarters
  • Figure 10.4 Cell Therapy Manufacturers: Distribution by Location of Headquarters (Country Wise)
  • Figure 10.5 Cell Therapy Manufacturers: Distribution by Location of Manufacturing Facility (Region-wise)
  • Figure 10.6 Cell Therapy Manufacturers: Distribution by Location of Manufacturing Facility (Country-wise)
  • Figure 10.7 Cell Therapy Manufacturers: Distribution by Type of Cells Manufactured
  • Figure 10.8 Cell Therapy Manufacturers: Distribution by Type of Manufacturers
  • Figure 10.9 Cell Therapy Manufacturers: Distribution by Source of Cells
  • Figure 10.10 Cell Therapy Manufacturers: Distribution by Scale of Operation
  • Figure 10.11 Cell Therapy Manufacturers: Distribution by Manufacturing Capabilities / Services
  • Figure 11.1 Global Cell Therapy Packaging Market, Forecasted Estimates (2024-2035) (USD Million)
  • Figure 11.2 Global Cell therapy Packaging Market, Forecasted Estimates (2024-2035), Conservative Scenario (USD Million)
  • Figure 11.3 Global Cell therapy Packaging Market, Forecasted Estimates (2024-2035), Optimistic Scenario (USD Million)
  • Figure 12.1 Cell Therapy Packaging Market: Distribution by Type of Therapy, 2024 and 2035 (USD Million)
  • Figure 12.2 Cell Therapy Packaging Market for T-cell Therapies Packaging, Forecasted Estimates (2024-2035) (USD Million)
  • Figure 12.3 Cell Therapy Packaging Market for Dendritic Cell Vaccines Packaging, Forecasted Estimates (2024-2035) (USD Million)
  • Figure 12.4 Cell Therapy Packaging Market for Stem Cell Therapies Packaging, Forecasted Estimates (2024-2035) (USD Million)
  • Figure 12.5 Cell Therapy Packaging Market for NK-Cell Therapies Packaging, Forecasted Estimates (2024-2035) (USD Million)
  • Figure 12.6 Cell Therapy Packaging Market for Other Advanced Therapy Medicinal Products Packaging, Forecasted Estimates (2024-2035) (USD Million)
  • Figure 13.1 Cell Therapy Packaging Market: Distribution by Scale of Operation, 2024 and 2035 (USD Million)
  • Figure 13.2 Cell Therapy Packaging Market for Clinical Scale, Forecasted Estimates (2024-2035) (USD Million)
  • Figure 13.3 Cell Therapy Packaging Market for Commercial Scale, Forecasted Estimates (2024-2035) (USD Million)
  • Figure 14.1 Cell Therapy Packaging Market: Distribution by Package Engineering Design, 2024 and 2035 (USD Million)
  • Figure 14.2 Cell Therapy Packaging Market for Primary Packaging, Forecasted Estimates (2024-2035) (USD Million)
  • Figure 14.3 Cell Therapy Packaging Market for Secondary Packaging, Forecasted Estimates (2024-2035) (USD Million)
  • Figure 15.1 Cell Therapy Packaging Market: Distribution by Key Geographical Regions, 2024 and 2035 (USD Million)
  • Figure 15.2 Cell Therapy Packaging Market in North America, Forecasted Estimates (2024-2035) (USD Million)
  • Figure 15.3 Cell Therapy Packaging Market in Europe, Forecasted Estimates (2024-2035) (USD Million)
  • Figure 15.4 Cell Therapy Packaging Market in Asia-Pacific, Forecasted Estimates (2024-2035) (USD Million)
  • Figure 15.5 Cell Therapy Packaging Market in Rest of The World, Forecasted Estimates (2024-2035) (USD Million)
  • Figure 16.1 Concluding Remarks: Overall Service Providers Landscape
  • Figure 16.2 Concluding Remarks: Overall Products Landscape
  • Figure 16.3 Concluding Remarks: Partnerships and Collaborations
  • Figure 16.4 Concluding Remarks: Likely Partner Analysis
  • Figure 16.5 Concluding Remarks: Market Forecast